SG11201912149WA - Tetrahydropyridopyrazine Modulators Of GPR6 - Google Patents

Tetrahydropyridopyrazine Modulators Of GPR6

Info

Publication number
SG11201912149WA
SG11201912149WA SG11201912149WA SG11201912149WA SG11201912149WA SG 11201912149W A SG11201912149W A SG 11201912149WA SG 11201912149W A SG11201912149W A SG 11201912149WA SG 11201912149W A SG11201912149W A SG 11201912149WA SG 11201912149W A SG11201912149W A SG 11201912149WA
Authority
SG
Singapore
Prior art keywords
tetrahydropyridopyrazine
gpr6
modulators
tetrahydropyridopyrazine modulators
Prior art date
Application number
SG11201912149WA
Other languages
English (en)
Inventor
Jason W Brown
Stephen Hitchcock
Maria Hopkins
Shota Kikuchi
Holger Monenschein
Holly Reichard
Kristin Schleicher
Huikai Sun
Todd Macklin
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of SG11201912149WA publication Critical patent/SG11201912149WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201912149WA 2017-06-15 2018-06-15 Tetrahydropyridopyrazine Modulators Of GPR6 SG11201912149WA (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762520430P 2017-06-15 2017-06-15
US201762591247P 2017-11-28 2017-11-28
US201862649856P 2018-03-29 2018-03-29
US201862672261P 2018-05-16 2018-05-16
PCT/US2018/037687 WO2018232202A1 (en) 2017-06-15 2018-06-15 Tetrahydropyridopyrazine modulators of gpr6

Publications (1)

Publication Number Publication Date
SG11201912149WA true SG11201912149WA (en) 2020-01-30

Family

ID=64656005

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201912149WA SG11201912149WA (en) 2017-06-15 2018-06-15 Tetrahydropyridopyrazine Modulators Of GPR6

Country Status (16)

Country Link
US (1) US10406157B2 (ja)
EP (1) EP3638673A4 (ja)
JP (2) JP7460369B2 (ja)
KR (1) KR20200014796A (ja)
CN (1) CN110730781B (ja)
AU (1) AU2018285677B2 (ja)
BR (1) BR112019026430A2 (ja)
CA (1) CA3067032A1 (ja)
CO (1) CO2019015086A2 (ja)
IL (1) IL271332B2 (ja)
JO (1) JOP20180057A1 (ja)
MX (1) MX2019014940A (ja)
PH (1) PH12019502792A1 (ja)
SG (1) SG11201912149WA (ja)
TW (1) TWI775874B (ja)
WO (1) WO2018232202A1 (ja)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US7229557B2 (en) * 2004-02-04 2007-06-12 Konec, Inc. Method to separate stereoisomers
EP2451281A4 (en) * 2009-07-09 2013-03-13 Merck Sharp & Dohme ANTAGONISTS OF OREXIN RECEPTORS BASED ON TETRAHYDRONAPHTHYRIDINE
JO3466B1 (ar) 2013-12-20 2020-07-05 Takeda Pharmaceuticals Co مواد ضابطة لتترا هيدرو بيريدوبيرازينات من gpr6
US10179783B2 (en) * 2014-02-14 2019-01-15 Taketa Pharmaceutical Company Limited Tetrahydropyridopyrazines as modulators of GPR6
MY184366A (en) * 2014-02-14 2021-04-01 Takeda Pharmaceuticals Co Pyrazines modulators of gpr6

Also Published As

Publication number Publication date
US20180360831A1 (en) 2018-12-20
IL271332B2 (en) 2023-02-01
KR20200014796A (ko) 2020-02-11
CO2019015086A2 (es) 2020-04-13
WO2018232202A1 (en) 2018-12-20
CN110730781B (zh) 2023-05-05
EP3638673A4 (en) 2021-03-24
PH12019502792A1 (en) 2020-09-14
CN110730781A (zh) 2020-01-24
EP3638673A1 (en) 2020-04-22
IL271332A (en) 2020-01-30
TWI775874B (zh) 2022-09-01
AU2018285677B2 (en) 2022-07-14
JP2022188199A (ja) 2022-12-20
BR112019026430A2 (pt) 2020-07-14
JP7460369B2 (ja) 2024-04-02
RU2019144408A3 (ja) 2021-09-07
IL271332B (en) 2022-10-01
MX2019014940A (es) 2020-02-19
JP2020523287A (ja) 2020-08-06
US10406157B2 (en) 2019-09-10
CA3067032A1 (en) 2018-12-20
JOP20180057A1 (ar) 2019-01-30
AU2018285677A1 (en) 2019-12-19
RU2019144408A (ru) 2021-07-15
TW201906844A (zh) 2019-02-16

Similar Documents

Publication Publication Date Title
IL283582A (en) ror - gamma modulators
HK1256599A1 (zh) ROR-γ的調節劑
IL274369A (en) Combined pressure pathway modulators
IL259342B (en) Modulators of chemokine receptors
HK1250999A1 (zh) Ror1-ror2結合的調節劑
IL274405A (en) Combined pressure pathway modulators
IL274368A (en) Combined pressure pathway modulators
IL274406A (en) Combined pressure pathway modulators
IL274367A (en) Combined pressure pathway modulators
IL272888B1 (en) Uses of piperidinyl-indole derivatives
GB201706477D0 (en) Modification of polypeptides
IL269409A (en) Combinations of chk1- and wee1 - inhibitors
IL268731A (en) New uses of anti-SIRPG antibodies
GB2600654B (en) Novel devices
IL281492A (en) Modulators of PNPLA3 expression
IL274627A (en) Solid state form of valbenazine
IL283967A (en) Modulators of hsd17b13 expression
IL266261A (en) ror-gamma modulators
GB201716468D0 (en) Modulators
ZA201606077B (en) Pyrazines modulators of gpr6
IL274231A (en) Modulators of ENAC expression
IL271359A (en) Modulators of alpha-synuclein
GB2563095B (en) Modulators
IL271332A (en) Tetrahydropyridopyrazine modulators of GPR6
GB201721386D0 (en) Chrondogy of time-wave